Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: A role for caveolin-1

British Journal of Haematology

Volumn 158, Issue 2, 2012, Pages 216-231

  Gilling, Christine E ^a   Mittal, Amit K ^a   Chaturvedi, Nagendra K ^a   Iqbal, Javeed ^b   Aoun, Patricia ^b   Bierman, Philip J ^a   Bociek, Robert G ^a   Weisenburger, Dennis D ^b   Joshi, Shantaram S ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Caveolin 1; Chronic lymphocytic leukaemia; Cytoskeletal regulators; Immune tolerance dysregulation; Migration

Indexed keywords

CAVEOLIN 1; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FIBROBLAST GROWTH FACTOR RECEPTOR 1; HEAT SHOCK PROTEIN 90; INTERLEUKIN 10 RECEPTOR ALPHA; INTERLEUKIN 22; MYC PROTEIN; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN BCL 2; PROTEIN C FOS; PROTEIN TYROSINE PHOSPHATASE SHP 1; STAT1 PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ACTIN POLYMERIZATION; ADULT; AGED; AKT1 GENE; ARTICLE; B LYMPHOCYTE; BCL2 GENE; BLOOD; BONE MARROW; CANCER IMMUNOLOGY; CAV1 GENE; CEBPA GENE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CTLA4 GENE; DIFFERENTIAL EXPRESSION; FEMALE; FGFR1 ISOFORM 8 GENE; FOXP3 GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ANALYSIS; HSP90 GENE; HUMAN; HUMAN CELL; IGFBP6 GENE; IL10RALPHA GENE; IL22 GENE; IMMUNOLOGICAL SYNAPSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; ONCOGENE; ONCOGENE C FOS; ONCOGENE C MYC; PDK1 GENE; PRIORITY JOURNAL; STAT1 GENE; T LYMPHOCYTE; TUMOR GROWTH; ZWINT GENE;

ADULT; AGED; AGED, 80 AND OVER; CAVEOLIN 1; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGICAL SYNAPSES; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN BINDING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84863427146     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09148.x     Document Type: Article

References (66)

1. Arpaia, E., Blaser, H., Quintela-Fandino, M., Duncan, G., Leong, H.S., Ablack, A., Nambiar, S.C., Lind, E.F., Silvester, J., Fleming, C.K., Rufini, A., Tusche, M.W., Brustle, A., Ohashi, P.S., Lewis, J.D. & Mak, T.W. (2011) The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk. Oncogene, 31, 884-896.
2. Bertilaccio, M.T., Scielzo, C., Muzio, M. & Caligaris-Cappio, F. (2010) An overview of chronic lymphocytic leukaemia biology. Best Practice and Research Clinical Haematology, 23, 21-32.
3. Billadeau, D.D. & Burkhardt, J.K. (2006) Regulation of cytoskeletal dynamics at the immune synapse: new stars join the actin troupe. Traffic, 7, 1451-1460.
4. Blundell, M.P., Worth, A., Bouma, G. & Thrasher, A.J. (2010) The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function. Disease Markers, 29, 157-175.
5. Burger, J.A. (2010) Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): from understanding the basics towards therapeutic targeting. Seminars in Cancer Biology, 20, 424-430.
6. Burger, M., Hartmann, T., Krome, M., Rawluk, J., Tamamura, H., Fujii, N., Kipps, T.J. & Burger, J.A. (2005) Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood, 106, 1824-1830.
7. Burger, J.A., Quiroga, M.P., Hartmann, E., Burkle, A., Wierda, W.G., Keating, M.J. & Rosenwald, A. (2009) High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation. Blood, 113, 3050-3058.
8. Burgermeister, E., Friedrich, T., Hitkova, I., Regel, I., Einwachter, H., Zimmermann, W., Rocken, C., Perren, A., Wright, M.B., Schmid, R.M., Seger, R. & Ebert, M.P. (2011) The Ras inhibitors caveolin-1 and docking protein 1 activate peroxisome proliferator-activated receptor γ through spatial relocalization at helix 7 of its ligand-binding domain. Molecular Cell Biology, 31, 3497-3510.
9. Caligaris-Cappio, F. (2003) Role of the microenvironment in chronic lymphocytic leukaemia. British Journal of Haematology, 123, 380-388.
10. Curiel, T.J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J.R., Zhang, L., Burow, M., Zhu, Y., Wei, S., Kryczek, I., Daniel, B., Gordon, A., Myers, L., Lackner, A., Disis, M.L., Knutson, K.L., Chen, L. & Zou, W. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Medicine, 10, 942-949.
11. + regulatory T cell-dependent and -independent control of allergic inflammation. Immunity, 29, 114-126.
12. Deaglio, S. & Malavasi, F. (2009) Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferation. Haematologica, 94, 752-756.
13. Deutsch, V., Perry, C. & Polliack, A. (2009) Expansion of regulatory T cells in B chronic lymphocytic leukemia: enhanced 'brakes' on host immunity. Leukemia and Lymphoma, 50, 687-688.
14. Edwards, D.C., Sanders, L.C., Bokoch, G.M. & Gill, G.N. (1999) Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signaling to actin cytoskeletal dynamics. Nature Cell Biology, 1, 253-259.
15. Finetti, F., Paccani, S.R., Rosenbaum, J. & Baldari, C.T. (2011) Intraflagellar transport: a new player at the immune synapse. Trends in Immunology, 32, 139-145.
16. Friedl, P., den Boer, A.T. & Gunzer, M. (2005) Tuning immune responses: diversity and adaptation of the immunological synapse. Nature Reviews Immunology, 5, 532-545.
17. Garcia-Cardena, G., Martasek, P., Masters, B.S., Skidd, P.M., Couet, J., Li, S., Lisanti, M.P. & Sessa, W.C. (1997) Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. Journal of Biological Chemistry, 272, 25437-25440.
18. Ghia, P. & Caligaris-Cappio, F. (2000) The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms. Advances in Cancer Research, 79, 157-173.
19. Goetz, J.G., Joshi, B., Lajoie, P., Strugnell, S.S., Scudamore, T., Kojic, L.D. & Nabi, I.R. (2008) Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1. Journal of Cell Biology, 180, 1261-1275.
20. Goetz, J.G., Minguet, S., Navarro-Lerida, I., Lazcano, J.J., Samaniego, R., Calvo, E., Tello, M., Osteso-Ibanez, T., Pellinen, T., Echarri, A., Cerezo, A., Klein-Szanto, A.J., Garcia, R., Keely, P.J., Sanchez-Mateos, P., Cukierman, E. & Del Pozo, M.A. (2011) Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell, 146, 148-163.
21. Gomez, T.S. & Billadeau, D.D. (2008) T cell activation and the cytoskeleton: you can't have one without the other. Advances in Immunology, 97, 1-64.
22. Gorgun, G., Holderried, T.A., Zahrieh, D., Neuberg, D. & Gribben, J.G. (2005) Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. The Journal of Clinical Investigation, 115, 1797-1805.
23. Gorgun, G., Ramsay, A.G., Holderried, T.A., Zahrieh, D., Le Dieu, R., Liu, F., Quackenbush, J., Croce, C.M. & Gribben, J.G. (2009) E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction. Proceedings of the National Academy of Sciences, 106, 6250-6255.
24. Hegde, G., Peterson, K., Emanuel, K., Mittal, A.K., Joshi, A.D., Dickinson, J.D., Kollessery, G.J., Bociek, R.G., Bierman, P.J., Vose, J.M., Weisenburger, D.D. & Joshi, S.S. (2008) Hedgehog-Induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target. Molecular Cancer Research, 6, 1928-1936.
25. Hu, M. & Polyak, K. (2008) Molecular characterisation of the tumour microenvironment in breast cancer. European Journal of Cancer, 44, 2760-2765.
26. Huang, Y. & Burkhardt, J.K. (2007) T-cell-receptor-dependent actin regulatory mechanisms. Journal of Cell Science, 120, 723-730.
27. Iqbal, J., Weisenburger, D.D., Greiner, T.C., Vose, J.M., McKeithan, T., Kucuk, C., Geng, H., Deffenbacher, K., Smith, L., Dybkaer, K., Nakamura, S., Seto, M., Delabie, J., Berger, F., Loong, F., Au, W.Y., Ko, Y.H., Sng, I., Armitage, J.O. & Chan, W.C. (2010) Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood, 115, 1026-1036.
28. Jak, M., Mous, R., Remmerswaal, E.B., Spijker, R., Jaspers, A., Yague, A., Eldering, E., Van Lier, R.A. & Van Oers, M.H. (2009) Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia. Leukemia and Lymphoma, 50, 788-801.
29. Jewell, A.P., Worman, C.P., Giles, F.J. & Goldstone, A.H. (1997) Serum levels of TNF, IL-6, and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy. Leukemia and Lymphoma, 24, 327-333.
30. Jimenez, C., Portela, R.A., Mellado, M., Rodriguez-Frade, J.M., Collard, J., Serrano, A., Martinez-A, C., Avila, J. & Carrera, A.C. (2000) Role of the PI3K regulatory subunit in the control of actin organization and cell migration. Journal of Cell Biology, 151, 249-262.
31. Joshi, A.D., Hegde, G.V., Dickinson, J.D., Mittal, A.K., Lynch, J.C., Eudy, J.D., Armitage, J.O., Bierman, P.J., Bociek, R.G., Devetten, M.P., Vose, J.M. & Joshi, S.S. (2007) ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia. Clinical Cancer Research, 13, 5295-5304.
32. Klemke, R.L., Cai, S., Giannini, A.L., Gallagher, P.J., de Lanerolle, P. & Cheresh, D.A. (1997) Regulation of cell motility by mitogen-activated protein kinase. Journal of Cell Biology, 137, 481-492.
33. Kremer, K.N., Humphreys, T.D., Kumar, A., Qian, N.X. & Hedin, K.E. (2003) Distinct role of ZAP-70 and Src homology 2 domain-containing leukocyte protein of 76 kDa in the prolonged activation of extracellular signal-regulated protein kinase by the stromal cell-derived factor-1 alpha/CXCL12 chemokine. Journal of Immunology, 171, 360-367.
34. Lee, K.H., Holdorf, A.D., Dustin, M.L., Chan, A.C., Allen, P.M. & Shaw, A.S. (2002) T cell receptor signaling precedes immunological synapse formation. Science, 295, 1539-1542.
35. Li, S., Couet, J. & Lisanti, M.P. (1996) Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. Journal of Biological Chemistry, 271, 29182-29190.
36. Mittal, A.K., Iqbal, J., Nordgren, T.M., Moragues, M., Bociek, R.G., Aoun, P., Weisenburger, D.D. & Joshi, S.S. (2008) Molecular basis of proliferation/survival and migration of CLL in peripheral blood, bone marrow, and lymph nodes. Blood (ASH Annual Meeting Abstracts) 112, Abstract 546.
37. Muzio, M., Scielzo, C., Frenquelli, M., Bachi, A., De Palma, M., Alessio, M., Ghia, P. & Caligaris-Cappio, F. (2007) HS1 complexes with cytoskeleton adapters in normal and malignant chronic lymphocytic leukemia B cells. Leukemia, 21, 2067-2070.
38. Navarro, A., Anand-Apte, B. & Parat, M.O. (2004) A role for caveolae in cell migration. FASEB Journal, 18, 1801-1811.
39. Nethe, M., Anthony, E.C., Fernandez-Borja, M., Dee, R., Geerts, D., Hensbergen, P.J., Deelder, A.M., Schmidt, G. & Hordijk, P.L. (2010) Focal-adhesion targeting links caveolin-1 to a Rac1-degradation pathway. Journal of Cell Science, 123, 1948-1958.
40. Niedermeier, M., Hennessy, B.T., Knight, Z.A., Henneberg, M., Hu, J., Kurtova, A.V., Wierda, W.G., Keating, M.J., Shokat, K.M. & Burger, J.A. (2009) Isoform-selective phosphoinositide 3′-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach. Blood, 113, 5549-5557.
41. Orabona, C., Puccetti, P., Vacca, C., Bicciato, S., Luchini, A., Fallarino, F., Bianchi, R., Velardi, E., Perruccio, K., Velardi, A., Bronte, V., Fioretti, M.C. & Grohmann, U. (2006) Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood, 107, 2846-2854.
42. Otani, H., Yoshioka, K., Nishikawa, H., Inagaki, C. & Nakamura, T. (2011) Involvement of Protein Kinase C and RhoA in Protease-Activated Receptor 1-Mediated F-Actin Reorganization and Cell Growth in Rat Cardiomyocytes. Journal of Pharmacological Sciences, 115, 135-143.
43. Pleyer, L., Egle, A., Hartmann, T.N. & Greil, R. (2009) Molecular and cellular mechanisms of CLL: novel therapeutic approaches. Nature Reviews Clinical Oncology, 6, 405-418.
44. Polyak, K., Haviv, I. & Campbell, I.G. (2009) Co-evolution of tumor cells and their microenvironment. Trends in Genetics, 25, 30-38.
45. Quiroga, M.P., Balakrishnan, K., Kurtova, A.V., Sivina, M., Keating, M.J., Wierda, W.G., Gandhi, V. & Burger, J.A. (2009) B-cell antigen receptor signaling enhanced chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406. Blood, 114, 1029-1037.
46. Radoja, S., Saio, M., Schaer, D., Koneru, M., Vukmanovic, S. & Frey, A.B. (2001) CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis. Journal of Immunology, 167, 5042-5051.
47. Ramsay, A.G., Johnson, A.J., Lee, A.M., Gorgun, G., Le Dieu, R., Blum, W., Byrd, J.C. & Gribben, J.G. (2008) Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. The Journal of Clinical Investigation, 118, 2427-2437.
48. Richardson, S.J., Matthews, C., Catherwood, M.A., Alexander, H.D., Carey, B.S., Farrugia, J., Gardiner, A., Mould, S., Oscier, D., Copplestone, J.A. & Prentice, A.G. (2006) ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL). Blood, 107, 3584-3592.
49. Ruiz, S., Santos, E. & Bustelo, X.R. (2007) RasGRF2, a guanosine nucleotide exchange factor for Ras GTPases, participates in T-cell signaling responses. Molecular Cell Biology, 27, 8127-8142.
50. Sasaki, H., Nishikata, I., Shiraga, T., Akamatsu, E., Fukami, T., Hidaka, T., Kubuki, Y., Okayama, A., Hamada, K., Okabe, H., Murakami, Y., Tsubouchi, H. & Morishita, K. (2005) Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood, 105, 1204-1213.
51. Schattner, E.J. (2000) CD40 ligand in CLL pathogenesis and therapy. Leukemia and Lymphoma, 37, 461-472.
52. Schollenberger, L., Gronemeyer, T., Huber, C.M., Lay, D., Wiese, S., Meyer, H.E., Warscheid, B., Saffrich, R., Peranen, J., Gorgas, K. & Just, W.W. (2010) RhoA regulates peroxisome association to microtubules and the actin cytoskeleton. PLoS ONE, 5, e13886.
53. Scielzo, C., Ghia, P., Conti, A., Bachi, A., Guida, G., Geuna, M., Alessio, M. & Caligaris-Cappio, F. (2005) HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses. The Journal of Clinical Investigation, 115, 1644-1650.
54. Scielzo, C., Ten Hacken, E., Bertilaccio, M.T., Muzio, M., Calissano, C., Ghia, P. & Caligaris-Cappio, F. (2010a) How the microenvironment shapes chronic lymphocytic leukemia: the cytoskeleton connection. Leukemia and Lymphoma, 51, 1371-1374.
55. Scielzo, C., Bertilaccio, M.T., Simonetti, G., Dagklis, A., Ten Hacken, E., Fazi, C., Muzio, M., Caiolfa, V., Kitamura, D., Restuccia, U., Bachi, A., Rocchi, M., Ponzoni, M., Ghia, P. & Caligaris-Cappio, F. (2010b) HS1 has a central role in the trafficking and homing of leukemic B cells. Blood, 116, 3537-3546.
56. Shojaei, F. & Ferrara, N. (2008) Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies. Drug Resistance Updates, 11, 219-230.
57. Shortman, K. & Naik, S.H. (2007) Steady-state and inflammatory dendritic-cell development. Nature Reviews Immunology, 7, 19-30.
58. Sloan, K.A., Marquez, H.A., Li, J., Cao, Y., Hinds, A., O'Hara, C.J., Kathuria, S., Ramirez, M.I., Williams, M.C. & Kathuria, H. (2009) Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines. Carcinogenesis, 30, 1433-1442.
59. -/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts. American Journal of Pathology, 174, 746-761.
60. Thrasher, A.J. & Burns, S.O. (2010) WASP: a key immunological multitasker. Nature Reviews Immunology, 10, 182-192.
61. Trimmer, C., Whitaker-Menezes, D., Bonuccelli, G., Milliman, J.N., Daumer, K.M., Aplin, A.E., Pestell, R.G., Sotgia, F., Lisanti, M.P. & Capozza, F. (2010) CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway. Cancer Research, 70, 7489-7499.
62. Wabnitz, G.H., Nebl, G., Klemke, M., Schroder, A.J. & Samstag, Y. (2006) Phosphatidylinositol 3-kinase functions as a Ras effector in the signaling cascade that regulates dephosphorylation of the actin-remodeling protein cofilin after costimulation of untransformed human T lymphocytes. Journal of Immunology, 176, 1668-1674.
63. Wary, K.K., Mariotti, A., Zurzolo, C. & Giancotti, F.G. (1998) A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell, 94, 625-634.
64. Wei, Y., Yang, X., Liu, Q., Wilkins, J.A. & Chapman, H.A. (1999) A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. Journal of Cell Biology, 144, 1285-1294.
65. Witkiewicz, A.K., Dasgupta, A., Sotgia, F., Mercier, I., Pestell, R.G., Sabel, M., Kleer, C.G., Brody, J.R. & Lisanti, M.P. (2009) An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. American Journal of Pathology, 174, 2023-2034.
66. Zenz, T., Mertens, D. & Stilgenbauer, S. (2010) Biological diversity and risk-adapted treatment of chronic lymphocytic leukemia. Haematologica, 95, 1441-1443.